Safety and Efficacy of Darunavir (TMC114) With Low-Dose Ritonavir in Treatment-Experienced Patients: 24-Week Results of POWER 3
暂无分享,去创建一个
C. Katlama | C. Cohen | J. Molina | B. Grinsztejn | R. J. Pedro | S. Meyer | T. Vangeneugden | W. Parys | D. Miralles | A. Timerman | E. Lefebvre | S. Meyer